.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The ACOSOG Z0011 trial changed the surgical management of selected patients with early-stage breast cancer and limited sentinel lymph node involvement. Women undergoing breast-conserving surgery with one or two positive sentinel nodes were randomized to completion axillary lymph node dissection or no further axillary surgery. At long-term follow-up, overall survival and disease-free survival were similar between the strategies. The study supported omission of routine axillary dissection in appropriately selected patients, provided they received breast-conserving treatment and whole-breast radiotherapy within the trial framework. The clinical importance is substantial because axillary lymph node dissection carries a meaningful risk of lymphedema and other morbidity. Avoiding unnecessary surgery can therefore preserve quality of life without compromising oncological outcomes in carefully selected patients. For surgeons, Z0011 is a model of de-escalation based on evidence rather than tradition. The findings should not be extrapolated indiscriminately to every patient with a positive sentinel node; eligibility, surgical context, tumour characteristics and radiotherapy plans matter. The study also illustrates how multidisciplinary care enables surgical de-escalation: breast surgeons, radiologists, pathologists, radiation oncologists and medical oncologists must align around the same treatment strategy.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The ACOSOG Z0011 trial changed the surgical management of selected patients with early-stage breast cancer and limited sentinel lymph node involvement. Women undergoing breast-conserving surgery with one or two positive sentinel nodes were randomized to completion axillary lymph node dissection or no further axillary surgery. At long-term follow-up, overall survival and disease-free survival were similar between the strategies. The study supported omission of routine axillary dissection in appropriately selected patients, provided they received breast-conserving treatment and whole-breast radiotherapy within the trial framework. The clinical importance is substantial because axillary lymph node dissection carries a meaningful risk of lymphedema and other morbidity. Avoiding unnecessary surgery can therefore preserve quality of life without compromising oncological outcomes in carefully selected patients. For surgeons, Z0011 is a model of de-escalation based on evidence rather than tradition. The findings should not be extrapolated indiscriminately to every patient with a positive sentinel node; eligibility, surgical context, tumour characteristics and radiotherapy plans matter. The study also illustrates how multidisciplinary care enables surgical de-escalation: breast surgeons, radiologists, pathologists, radiation oncologists and medical oncologists must align around the same treatment strategy.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
